COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

Role of Anticoagulants and Antiplatelet Agents for Patients With COV…

CHEST 2022 Coverage

V. Balasubramanian

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Pulmonary Embolism: Role of Catheter-Based Interventions

Baylor College of Medicine

P. Loyalka

The ABCs of the CBC - Overview and Practical Insights on RBC Paramet…

The Blood Project

W. Aird

Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

Clots in the Visceral and Cerebral Veins: Evidence, Guidelines and T…

Marc Zumberg

Challenges in Antithrombotic Management: Top 3 Challenges in 2023 fo…

James Douketis

Hematologic Emergencies - Bleeding to Clotting

Medical College of Georgia - Augusta University

G. Raval

Classical Hematology: Managing Disorders of Bleeding and Clotting

Indy Hematology Review

C. Kessler

2024 Benign Hematology Updates

University of Colorado Division of Hematology

L. Chu

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Exercises in CBC Interpretation - Focus on WBCs and Platelets

The Blood Project

W. Aird

State-of-the-Art in ITP: Updates and Remaining Challenges

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

D. Provan

ASH 2023 Summary: "Updates in VEXAS Syndrome and PNH"

BMFcases

T. Bat, I. Ibrahim, Y. Shen

Switching ITP Patients to Avatrombopag From Other TPO-RAs: When to D…

Keck School of Medicine of USC

H. Liebman

How to Manage Anticoagulation in Patients With Inherited Bleeding Di…

Bethany Samuelson Bannow